In December 2023, the National Institute for Health and Care Excellence (NICE) published technology appraisal guidance (TA943) recommending hybrid closed-loop (HCL) systems as an option for managing blood glucose levels for adults living with Type 1 diabetes (T1D).1 NICE agreed to an NHS England request to extend the normal period of compliance to 5 years to allow specialist services time to develop education and training to support wider access.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with L.
Contact L., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack